Valuation: Boule Diagnostics AB

Market Cap 139M 14.35M 12.58M 11.6M 10.86M 20.36M 1.35B 20.79M 53.94M 669M 53.89M 52.71M 2.32B P/E 2026 *
-14.3x
P/E 2027 * 16.2x
Enterprise Value 336M 34.58M 30.32M 27.95M 26.17M 49.07M 3.26B 50.09M 130M 1.61B 130M 127M 5.59B EV / Sales 2026 *
0.74x
EV / Sales 2027 * 0.67x
Free-Float
50.4%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-06-21
Director of Finance/CFO 54 2026-02-10
Chief Executive Officer - 2024-04-15
Director TitleAgeSince
Director/Board Member 59 2013-12-31
Chairman 73 2020-12-31
Chairman 74 2022-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+6.05%+1.76% - - 14.36M
+1.44%+10.56%+24.49%-1.72% 188B
+1.25%+0.43%-24.24%+24.46% 142B
+1.75%+10.10%-2.62%-17.53% 137B
+0.07%-0.23%-57.71%-17.33% 65.7B
+1.18%+5.71%+17.67%+1.44% 51.66B
-0.52%-0.61%-27.14%-33.22% 43.7B
+0.37%+7.53%+13.89%+14.90% 38.27B
-0.66%+4.51%+5.49%+44.15% 37.01B
+1.26%+8.44%-12.16%-15.48% 29.54B
Average +1.29%+2.98%-6.93%-0.03% 81.35B
Weighted average by Cap. +1.08%+3.25%-3.93%-0.04%

Financials

2026 *2027 *
Net sales 453M 46.65M 40.9M 37.7M 35.29M 66.18M 4.4B 67.56M 175M 2.17B 175M 171M 7.54B 483M 49.76M 43.63M 40.21M 37.65M 70.59M 4.69B 72.06M 187M 2.32B 187M 183M 8.04B
Net income -9.77M -1.01M -882K -813K -761K -1.43M -94.91M -1.46M -3.78M -46.91M -3.78M -3.7M -163M 8.6M 885K 776K 715K 670K 1.26M 83.48M 1.28M 3.33M 41.26M 3.32M 3.25M 143M
Net Debt 197M 20.23M 17.74M 16.35M 15.31M 28.71M 1.91B 29.3M 76.05M 943M 75.97M 74.32M 3.27B 185M 18.99M 16.65M 15.35M 14.37M 26.95M 1.79B 27.51M 71.4M 886M 71.33M 69.77M 3.07B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
-